The West Jordan Journal is the local newspaper covering news and events in the City of West Jordan, Utah. The West Jordan Journal provides one of the best advertising channels to the residents of the City of West Jordan.

West Jordan Journal | Educating | Entertaining | Informing | Press Releases

Wanclouds Inc

Wanclouds Launches AI Assistant to Transform IT &amp; Cloud Infrastructure Management, Announces Expansion into Saudi Arabia

Rapidtek Technologies Inc.

Rapidtek Successfully Launches Black Kite-1 with TASA to Advance LEO IoT Constellation

Super Bowl LX Pregame Entertainment Lineup Revealed

China Daily

Female model workers sharing expertise with enterprises

The Rosen Law Firm PA

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

Coda

Coda Announces Partnership with Itemmania to Expand Game Top-Up Access in South Korea

transcosmos inc.

transcosmos Earns Top Gold Rating for Second Consecutive Year in &quot;PRIDE Index 2025&quot; for LGBTQ+ Workplace Initiatives

Zuellig Pharma unveils state-of-the-art Clinical Trial Support Innovation Center in South Korea to support both domestic and global clinical research needs

New facility is set to be South Korea’s most advanced automated hub for clinical logistics and sourcing, reinforcing the nation’s position as a leader in clinical research innovation

GYEONGGI-DO, SOUTH KOREA -  Media OutReach Newswire - 1 December 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced the grand opening of its new state-of-the-art Clinical Trial Support (CTS) Innovation Center in South Korea. 
  The opening of this facility underscores Zuellig Pharma's continued investment and commitment to advancing healthcare, reinforcing its position as a trusted regional partner in driving meaningful outcomes for patients, partners, and communities across the region. 
  Strategically located near the Gyeongbu Expressway in Gyeonggi-do province, the new 3,800-square-meter facility is set to redefine standards in clinical trial logistics through automation, digitalization, and stringent Good Practice (GxP) compliance. It is designed to enhance operational efficiency, scalability, and reliability across diverse therapeutic areas. 
  "As part of an integrated healthcare solutions company, this milestone marks a significant step forward for Zuellig Pharma in remaining agile and responsive to the evolving clinical trial landscape. It also reflects Zuellig Pharma's continued commitment to advancing healthcare through innovation and sustainable infrastructure, creating greater access to treatments and delivering meaningful outcomes for partners and communities we serve," said John Graham, CEO of Zuellig Pharma. 
  The facility is equipped with advanced capabilities that set new standards for clinical trial logistics. It features a fully automated order fulfillment system that enhances the speed, accuracy, and reliability of clinical supply delivery. Its flexible and scalable architecture ensures uninterrupted operations, while robust cybersecurity measures safeguard sensitive clinical trial data. 
  In addition, the facility provides comprehensive temperature-zone support, enabling Zuellig Pharma to manage thousands of unique clinical trial SKUs under strict ambient, cold, frozen, deep frozen, cryogenic and return storage conditions. This ensures that temperature-sensitive products are handled with the highest level of precision throughout the entire supply chain. 
  Designed with precision, the facility's specialized repackaging infrastructure is built to accommodate controlled environments tailored to ambient, cold, frozen, and amber light repackaging specifications. These environments meet stringent clinical and regulatory standards, ensuring product integrity is maintained throughout the clinical trial lifecycle. Furthermore, an integrated end-to-end tracking and monitoring system provides full chain-of-custody, complete traceability, and adherence to GxP requirements, reinforcing quality and compliance at every stage. 
  "As of 2025, South Korea ranks among the world's top 10 clinical trials markets and holds the third-largest number of R&D pipelines globally. Our new facility has been built to meet this rising demand, redefining how investigational products are stored, managed, and distributed. With precision in mind, we aim to enable the reliable delivery of critical therapies to improve patient access and outcomes worldwide," added Giuseppe Leo, SVP, Clinical Trial Support Business Unit Lead, Zuellig Pharma. 
  Over the past year, the center has supported over 3,000 cumulative studies in collaboration with more than 100 clients, managing an annual volume of approximately 13,000 outbound shipments, including chemical, biologics, medical devices and cellular and gene therapies. Its extensive track record includes partnerships with 14 of the world's top 20 pharmaceutical companies and 8 of the top 10 global CROs, underscoring its position as a trusted partner in global clinical trial research. 
 Hashtag: #ZuelligPharma #ClinicalTrials #Automation #Healthcare #Pharmaceuticals #ColdChain #Logistics

https://www.zuelligpharma.com/
https://www.linkedin.com/company/zuellig-pharma
The issuer is solely responsible for the content of this announcement.

About Zuellig Pharma
Zuellig Pharma is a leading healthcare solutions company in Asia, and our purpose is to make healthcare more accessible to the communities we serve. We provide world-class distribution, commercialization, and clinical trial support services, underpinned by a strong culture of innovation to support the growing healthcare needs in this region. The company was founded a hundred years ago and has grown to become a multibillion-dollar business covering 18 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world.

MiniTool Software Limited

MiniTool Released MovieMaker 8.4.0 with Bubble Text for Your Creative Videos

Loka

Loka Achieves AWS Agentic AI Specialization

CASIO COMPUTER CO., LTD

Casio to Release 25 Design Calculators

Monster Energy

Monster Energy's Troy Podmilsak Earns Victory in Men's Freeski Big Air at FIS World Cup in Secret Garden, China

Innovative Solutions

Innovative Solutions Achieves the AWS Agentic AI Specialization

METAOPTICS LTD

MetaOptics Announces Strategic Share Placement to Accelerate Growth and Meet Rising Global Demand

Brawn

Helios 50 MW BESS achieves commercial operations in Hokkaido, Japan

Wolf Haldenstein Adler Freeman &amp; Herz LLP

Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately

Lead Plaintiff Deadline is January 9, 2026

HRL Investor News: If You Have Suffered Losses in Hormel Foods Corporation (NYSE: HRL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

24 Exchange

24X National Exchange Welcomes Strategic Equity Investment from Shinhan Securities of Korea

GeeFi Tech LLC

GeeFi (GEE) Wins Retail Trust Over Avalanche (AVAX), Phase 2 Start Brings 667% Prediction Near Reality

Shareholders who lost money in shares of Jayud Global Logistics Limited (NASDAQ : JYD) Should Contact Wolf Haldenstein Immediately